RBC

Roble Belko & Company Portfolio holdings

AUM $787M
1-Year Est. Return 16.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+16.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$763M
AUM Growth
+$25.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
535
New
Increased
Reduced
Closed

Top Sells

1 +$4.26M
2 +$983K
3 +$556K
4
VV icon
Vanguard Large-Cap ETF
VV
+$367K
5
SCHB icon
Schwab US Broad Market ETF
SCHB
+$352K

Sector Composition

1 Technology 1.73%
2 Financials 1.46%
3 Consumer Discretionary 0.93%
4 Healthcare 0.45%
5 Industrials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OS
451
DELISTED
OneStream Inc
OS
$1K ﹤0.01%
33
GSOL
452
Grayscale Solana Staking ETF Shares
GSOL
$48.5M
$1K ﹤0.01%
+120
SOLS
453
Solstice Advanced Materials
SOLS
$12.7B
$1K ﹤0.01%
+20
DEFT
454
Defi Technologies
DEFT
$293M
-50
XYZ
455
Block Inc
XYZ
$41.1B
$0 ﹤0.01%
4
ETHE
456
Grayscale Ethereum Staking ETF Shares
ETHE
$1.99B
-93
PDYN icon
457
Palladyne AI
PDYN
$308M
$0 ﹤0.01%
101
+30
MSTY icon
458
YieldMax MSTR Option Income Strategy ETF
MSTY
$1.16B
$0 ﹤0.01%
3
XSVM icon
459
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$593M
$0 ﹤0.01%
7
XOP icon
460
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.36B
-13
VSH icon
461
Vishay Intertechnology
VSH
$3.57B
$0 ﹤0.01%
5
VONG icon
462
Vanguard Russell 1000 Growth ETF
VONG
$41.2B
$0 ﹤0.01%
2
VKTX icon
463
Viking Therapeutics
VKTX
$4.12B
-25
VICI icon
464
VICI Properties
VICI
$30.4B
-33
UEC icon
465
Uranium Energy
UEC
$7.43B
$0 ﹤0.01%
+9
UBER icon
466
Uber
UBER
$156B
$0 ﹤0.01%
3
-153
UAA icon
467
Under Armour
UAA
$2.67B
$0 ﹤0.01%
9
TMUS icon
468
T-Mobile US
TMUS
$217B
-35
STLA icon
469
Stellantis
STLA
$23.6B
$0 ﹤0.01%
30
SRFM icon
470
Surf Air Mobility
SRFM
$96.2M
$0 ﹤0.01%
+10
SONY icon
471
Sony
SONY
$127B
$0 ﹤0.01%
5
SMH icon
472
VanEck Semiconductor ETF
SMH
$50.9B
-64
SE icon
473
Sea Limited
SE
$53.5B
$0 ﹤0.01%
1
SCM icon
474
Stellus Capital Investment Corp
SCM
$284M
-14
RXRX icon
475
Recursion Pharmaceuticals
RXRX
$1.9B
-141